Related Experiment Video

Updated: Jul 20, 2026

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury
04:03

Stab-Wound Mouse Model for Studying Hemorrhage and Inflammation in Traumatic Brain Injury

Published on: February 21, 2025

[Influence of intravascular coagulation on brain injury and clinical course in purulent meningitis]

Maciej Michał Kowalik1

  • 1Klinika Chorób Zakaźnych, Instytut Chorób Akademii Medycznej w Gdańsku. mkowalik@amg.gda.pl

Przeglad Epidemiologiczny
|September 13, 2006
PubMed

Insights

Purulent meningitis (PM) can lead to severe neurological issues and death, often due to hypoxia and brain swelling. Anticoagulant therapies may improve outcomes by addressing complications like disseminated intravascular coagulation (DIC).

Area of Science:

  • Neurology
  • Infectious Diseases
  • Hematology

Context:

  • Purulent meningitis (PM) presents a significant risk, with 30-40% of patients experiencing severe neurological complications or death.
  • Neuronal damage in PM is frequently caused by toxin-induced apoptosis and hypoxia, stemming from cerebral edema and hypoperfusion.
  • Hypoperfusion is exacerbated by impaired cerebral autoregulation and the pro-thrombotic state of disseminated intravascular coagulation (DIC).

Purpose:

  • To highlight the under-explained influence of DIC on patient prognosis in purulent meningitis.
  • To review the limited but potentially beneficial use of anticoagulants, such as heparins, in managing PM.
  • To advocate for epidemiological studies and multivariate analyses to clarify DIC's role and impact on outcomes in PM.

Summary:

  • Disseminated intravascular coagulation (DIC) occurs in approximately 40% of purulent meningitis cases, significantly impacting prognosis.
  • Cerebral edema and hypoperfusion, driven by elevated intracranial pressure and loss of autoregulation, contribute to hypoxia and neuronal death.
  • Anticoagulant therapies, particularly heparins, show potential benefits in improving outcomes for patients with PM and associated DIC.

Impact:

  • Further research into DIC staging and its correlation with outcomes in PM is crucial.
  • Anticoagulant drugs warrant consideration as an adjunct to supportive therapy to improve patient prognoses.
  • Understanding and managing DIC in purulent meningitis could significantly reduce mortality and neurological sequelae.

More Related Videos

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation06:50

A Preclinical Controlled Cortical Impact Model for Traumatic Hemorrhage Contusion and Neuroinflammation

Published on: June 10, 2020

Related Concept Videos

Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...